Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Neoadjuvant mFOLFIRINOX vs mFOLFIRINOX Plus Radiotherapy in Patients With Borderline Resectable Pancreatic Cancer-The A021501 Trial. JAMA Oncol 2023 Feb 01;9(2):275-276

Date

12/02/2022

Pubmed ID

36454556

DOI

10.1001/jamaoncol.2022.6138

Scopus ID

2-s2.0-85148307010 (requires institutional sign-in at Scopus site)   1 Citation

Author List

Hall WA, Evans DB, Tsai S

Authors

Douglas B. Evans MD Chair, Professor in the Surgery department at Medical College of Wisconsin
William Adrian Hall MD Professor in the Radiation Oncology department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Antineoplastic Combined Chemotherapy Protocols
Fluorouracil
Humans
Neoadjuvant Therapy
Pancreatic Neoplasms